The COVID-19 vaccine made by U.S.-based Novavax can lead to the same types of heart inflammation that have occurred after vaccination with the Pfizer and Moderna shots, Europe’s drug regulator said on Aug. 3.
The European Medicines Agency said the vaccine, known as Nuvaxovid, should have myocarditis and pericarditis listed as side effects in the product information for the vaccine.
